Titlebook: Biosimilars for Cancer Treatment; A Promising Approach Shvetank Bhatt,Harish Dureja,Kamal Dua Book 2024 The Editor(s) (if applicable) and T

只看該作者 · 發(fā)表于 2025-3-30 12:05:21

Book 2024t focus on the clinical trials of biosimilars, providing insights into the latest research and developments...This book serves as a valuable resource for clinicians, researchers, and anyone seeking a comprehensive understanding of the intersection between biosimilars and cancer treatment..

只看該作者 · 發(fā)表于 2025-3-30 14:20:25

只看該作者 · 發(fā)表于 2025-3-30 16:50:24

只看該作者 · 發(fā)表于 2025-3-30 21:13:09

只看該作者 · 發(fā)表于 2025-3-31 02:15:18

Prostate Cancer Bone Metastasisproved according to the same standards of pharmaceutical quality, safety and efficacy that apply to all biological medicines. It works smoothly and efficiently for both acute and chronic illnesses. In the biological treatment of oncology, the high production cost causes burdensome to healthcare syst

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 14:14
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved